23/02/2026
Scientific research on cannabis-based compounds continues to grow — and the findings are nuanced.
A landmark report from the National Academies of Sciences reviewed hundreds of peer-reviewed studies and found strong evidence supporting the use of cannabis-derived compounds for:
• Chronic pain
• Chemotherapy-related nausea and vomiting
• Muscle spasticity associated with multiple sclerosis
The report also identified evidence for improving sleep disturbances, particularly when linked to pain or neurological conditions.
For many other health conditions, evidence remains limited or insufficient — not necessarily because these compounds don’t work, but because high-quality human trials are still developing. Researchers consistently emphasise that outcomes depend on dosage, formulation, individual biology, and proper medical supervision.
Importantly, gaps remain in long-term safety data, especially regarding frequent or unsupervised use. The scientific consensus supports targeted, evidence-based medical applications — not broad or universal claims.
As research advances, scientists are continuing to explore how specific cannabis compounds interact with the body’s nervous, immune, and pain-regulation systems to better guide clinical practice.
Science evolves — and responsible conversations should evolve with it.